StockMacro
Company, fund or insider

Help

Menu

Glaukos

GKOS on XNYS, Glaukos Corporation

Measures activity, not value. Not investment advice.

Latest month (Mar 2026)

$169K

7.9× the 3-year median

Last 12 months

$233K

-57% vs the 12 months before

Sharp changes

0

federal obligations jump, first federal award, first award from a new federal agency

Window
Record type

What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

Federal obligations: $169K in March 2026, 7.9× the 3-year median

USAspending.gov obligations by date. Dashed: 3-year median. Incomplete recent periods left out (91-day reporting lag).

See the numbers
Month of Mar 2026: $169K
Month of Jan 2026: -$117K
Month of Aug 2025: $11K
Month of May 2025: $128K
Month of Apr 2025: $43K
Month of Jan 2025: $21K
Month of Sep 2024: $21K
Month of Aug 2024: $11K
Month of Jul 2024: $213K
Month of Jun 2024: $277K

What the numbers say

  • Federal obligations: $169K in March 2026, 7.9× the 3-year median; the most since Jul 2024.
  • Federal obligations over 12 months: $31K, number 85 of 120 Health Care companies with data (median $214K).

Every measure from this source

5 years, by the period each figure describes

Obligations (contracts + grants). $233K in the last 12 months, -57% on the year before.
Contract obligations. $233K in the last 12 months, -57% on the year before.
New awards. 11 in the last 12 months, +38% on the year before.

Sharp changes

0 in all loaded history, strongest first

No sharp change of this kind in all loaded history.

The records

Newest first, by the day each became public

No records in all loaded history with these filters.